$0.01 0.0 0.0%
Last Trade - 01/03/21
| Market Cap | £803k |
| Enterprise Value | £9.81m |
| Revenue | £115k |
| Position in Universe | th / 6633 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010E | 2011E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.24 | 0.18 | 0.062 | 0.24 | 0.27 | 0.041 | -29.7% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
BioSyntech, Inc. is a development-stage company. The Company develops advanced biotherapeutic thermogels specifically designed for tissue repair and delivery of therapeutic agents. It focuses its efforts on the development of its lead program BST-CarGel, a natural biopolymer derived from the shells of crustaceans. Using its BST-Gel technology platform, BST-CarGel is being developed as a treatment for the regeneration of cartilage in the knee. BioSyntech is developing a first product for cartilage repair and it has reached clinical trial stage.
| Last Annual | March 31st, 2009 |
| Last Interim | December 31st, 2009 |
| Incorporated | December 15, 1994 |
| Public Since | January 10, 2000 |
| No. of Shareholders: | n/a |
| No. of Employees: | 20 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 116,441,283 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 475 Armand-Frappier Blvd, LAVAL, H7V 4B3, Canada |
| Web | |
| Phone | +1 450 6862437 |
| Auditors | KPMG LLP |
As of 01/03/21, shares in Biosyntech Inc are trading at $0.01, giving the company a market capitalisation of £803k. This share price information is delayed by 15 minutes.
Shares in Biosyntech Inc are currently trading at $0.01 and the price has moved by 0.317k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biosyntech Inc price has moved by 0.233k% over the past year.
There are no analysts currently covering Biosyntech Inc.
Biosyntech Inc is scheduled to issue upcoming financial results on the following dates:
Biosyntech Inc does not currently pay a dividend.
Biosyntech Inc does not currently pay a dividend.
Biosyntech Inc does not currently pay a dividend.
To buy shares in Biosyntech Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Biosyntech Inc are currently trading at $0.01, giving the company a market capitalisation of £803k.
Here are the trading details for Biosyntech Inc:
We were not able to load our ranking data for Biosyntech Inc
We were not able to load any forecast data for Biosyntech Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biosyntech Inc. Over the past six months, the relative strength of its shares against the market has been 0.178k%. At the current price of $0.01, shares in Biosyntech Inc are trading at 0.127k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Biosyntech Inc.
Biosyntech Inc's management team is headed by:
Here are the top five shareholders of Biosyntech Inc based on the size of their shareholding:
